TG Therapeutics, Inc. (TGTX) stock
TGTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3010% above fair value
$66.12+3.41 (+5.44%)
Close on Nov 18, 2026Market cap $10.12BP/E 24.1Yield –
TG Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
TG Therapeutics's market cap was $10.07B on Nov 11, 2026, against $5.16B a year earlier. Over the last 5 years it ranged from $614.30M to $10.07B, with a median of $3.63B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $10.07B | +117.6% |
| 2025 | Dec 31, 2025 | $4.63B | -1.3% |
| 2024 | Dec 31, 2024 | $4.69B | +81.3% |
| 2023 | Dec 29, 2023 | $2.59B | +50.4% |
| 2022 | Dec 30, 2022 | $1.72B | -36.7% |
| 2021 | Dec 31, 2021 | $2.72B | -59.5% |
| 2020 | Dec 31, 2020 | $6.71B | +525.3% |
| 2019 | Dec 31, 2019 | $1.07B | +215.4% |
| 2018 | Dec 31, 2018 | $340.02M | -41.3% |
| 2017 | Dec 29, 2017 | $579.35M | +127.7% |
| 2016 | Dec 30, 2016 | $254.47M | -59.4% |
| 2015 | Dec 31, 2015 | $626.53M | -4.6% |
| 2014 | Dec 31, 2014 | $656.41M | +403.9% |
| 2013 | Dec 31, 2013 | $130.26M | +98.2% |
| 2012 | Dec 31, 2012 | $65.72M | +44313.3% |
| 2011 | Dec 30, 2011 | $147.97K | – |
See a number that looks wrong?